US Stock MarketDetailed Quotes

Design Therapeutics (DSGN)

Watchlist
  • 13.300
  • -0.300-2.21%
Close May 1 16:00 ET
  • 13.300
  • 0.0000.00%
Post 17:13 ET
830.68MMarket Cap-11.08P/E (TTM)

Design Therapeutics (DSGN) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.13%-16.43M
-26.11%-54.36M
-21.36%-11.97M
-16.93%-11.16M
-28.25%-14.44M
-34.97%-16.79M
26.39%-43.11M
22.96%-9.86M
34.32%-9.55M
18.43%-11.26M
Net income from continuing operations
0.45%-17.64M
-40.74%-69.79M
-17.19%-16M
-30.36%-17M
-61.82%-19.08M
-59.52%-17.72M
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
Depreciation and amortization
-1.26%157K
4.36%622K
4.70%156K
1.31%155K
0.66%152K
11.19%159K
10.99%596K
7.97%149K
11.68%153K
13.53%151K
Other non cash items
1,825.00%69K
6,666.67%406K
-166.67%-8K
-800.00%-7K
10,525.00%425K
-200.00%-4K
-81.82%6K
-160.00%-3K
-87.50%1K
-60.00%4K
Change In working capital
-63.82%-2.8M
413.19%3.11M
-40.45%960K
70.78%2.86M
173.74%994K
41.79%-1.71M
-236.40%-993K
181.13%1.61M
519.25%1.68M
-136.75%-1.35M
-Change in prepaid assets
79.60%-287K
-708.85%-1.38M
-245.45%-880K
-30.45%459K
171.97%452K
-242.34%-1.41M
-88.55%226K
-26.49%605K
203.29%660K
-205.02%-628K
-Change in payables and accrued expense
-734.22%-2.51M
468.01%4.49M
82.72%1.84M
136.48%2.41M
175.28%542K
88.07%-301K
2.17%-1.22M
135.84%1.01M
325.52%1.02M
-123.45%-720K
Cash from discontinued investing activities
Operating cash flow
2.13%-16.43M
-26.11%-54.36M
-21.36%-11.97M
-16.93%-11.16M
-28.25%-14.44M
-34.97%-16.79M
26.39%-43.11M
22.96%-9.86M
34.32%-9.55M
18.43%-11.26M
Investing cash flow
Cash flow from continuing investing activities
-196.43%-7.59M
-47.87%22.91M
-732.26%-11.58M
211.74%6.51M
-26.40%20.12M
-61.83%7.87M
-16.33%43.96M
-67.02%1.83M
-138.16%-5.83M
128.12%27.33M
Net PPE purchase and sale
--0
43.24%-193K
---34K
--0
45.96%-87K
63.08%-72K
-32.81%-340K
--0
130.19%16K
-80.90%-161K
Net investment purchase and sale
-195.56%-7.59M
-47.84%23.11M
-730.40%-11.55M
211.43%6.51M
-26.52%20.2M
-61.84%7.94M
-16.10%44.3M
-67.18%1.83M
-138.14%-5.84M
127.77%27.49M
Cash from discontinued investing activities
Investing cash flow
-196.43%-7.59M
-47.87%22.91M
-732.26%-11.58M
211.74%6.51M
-26.40%20.12M
-61.83%7.87M
-16.33%43.96M
-67.02%1.83M
-138.16%-5.83M
128.12%27.33M
Financing cash flow
Cash flow from continuing financing activities
86,569.57%19.93M
4,917.15%25.74M
9,526.24%25.32M
3,600.00%37K
57.64%361K
15.00%23K
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
Net common stock issuance
--19.91M
--24.85M
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
17.39%27K
73.68%891K
78.71%470K
3,600.00%37K
57.64%361K
15.00%23K
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
Cash from discontinued financing activities
Financing cash flow
86,569.57%19.93M
4,917.15%25.74M
9,526.24%25.32M
3,600.00%37K
57.64%361K
15.00%23K
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
Net cash flow
Beginning cash position
-25.29%16.86M
6.43%22.56M
-50.25%15.09M
-56.89%19.7M
-53.51%13.67M
6.43%22.56M
-20.00%21.2M
8.54%30.33M
68.03%45.7M
2.04%29.4M
Current changes in cash
54.07%-4.09M
-518.71%-5.71M
122.77%1.77M
69.98%-4.62M
-62.97%6.04M
-208.53%-8.9M
125.72%1.36M
-15.17%-7.77M
-2,163.22%-15.37M
1,111.29%16.3M
End cash Position
-6.56%12.77M
-25.29%16.86M
-25.29%16.86M
-50.25%15.09M
-56.89%19.7M
-53.51%13.67M
6.43%22.56M
6.43%22.56M
8.54%30.33M
68.03%45.7M
Free cash flow
2.55%-16.43M
-25.56%-54.55M
-21.70%-12M
-17.12%-11.16M
-27.20%-14.53M
-33.46%-16.86M
26.13%-43.45M
23.12%-9.86M
34.67%-9.53M
17.79%-11.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.13%-16.43M-26.11%-54.36M-21.36%-11.97M-16.93%-11.16M-28.25%-14.44M-34.97%-16.79M26.39%-43.11M22.96%-9.86M34.32%-9.55M18.43%-11.26M
Net income from continuing operations 0.45%-17.64M-40.74%-69.79M-17.19%-16M-30.36%-17M-61.82%-19.08M-59.52%-17.72M25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M
Depreciation and amortization -1.26%157K4.36%622K4.70%156K1.31%155K0.66%152K11.19%159K10.99%596K7.97%149K11.68%153K13.53%151K
Other non cash items 1,825.00%69K6,666.67%406K-166.67%-8K-800.00%-7K10,525.00%425K-200.00%-4K-81.82%6K-160.00%-3K-87.50%1K-60.00%4K
Change In working capital -63.82%-2.8M413.19%3.11M-40.45%960K70.78%2.86M173.74%994K41.79%-1.71M-236.40%-993K181.13%1.61M519.25%1.68M-136.75%-1.35M
-Change in prepaid assets 79.60%-287K-708.85%-1.38M-245.45%-880K-30.45%459K171.97%452K-242.34%-1.41M-88.55%226K-26.49%605K203.29%660K-205.02%-628K
-Change in payables and accrued expense -734.22%-2.51M468.01%4.49M82.72%1.84M136.48%2.41M175.28%542K88.07%-301K2.17%-1.22M135.84%1.01M325.52%1.02M-123.45%-720K
Cash from discontinued investing activities
Operating cash flow 2.13%-16.43M-26.11%-54.36M-21.36%-11.97M-16.93%-11.16M-28.25%-14.44M-34.97%-16.79M26.39%-43.11M22.96%-9.86M34.32%-9.55M18.43%-11.26M
Investing cash flow
Cash flow from continuing investing activities -196.43%-7.59M-47.87%22.91M-732.26%-11.58M211.74%6.51M-26.40%20.12M-61.83%7.87M-16.33%43.96M-67.02%1.83M-138.16%-5.83M128.12%27.33M
Net PPE purchase and sale --043.24%-193K---34K--045.96%-87K63.08%-72K-32.81%-340K--0130.19%16K-80.90%-161K
Net investment purchase and sale -195.56%-7.59M-47.84%23.11M-730.40%-11.55M211.43%6.51M-26.52%20.2M-61.84%7.94M-16.10%44.3M-67.18%1.83M-138.14%-5.84M127.77%27.49M
Cash from discontinued investing activities
Investing cash flow -196.43%-7.59M-47.87%22.91M-732.26%-11.58M211.74%6.51M-26.40%20.12M-61.83%7.87M-16.33%43.96M-67.02%1.83M-138.16%-5.83M128.12%27.33M
Financing cash flow
Cash flow from continuing financing activities 86,569.57%19.93M4,917.15%25.74M9,526.24%25.32M3,600.00%37K57.64%361K15.00%23K-29.14%513K-47.50%263K-92.31%1K9.05%229K
Net common stock issuance --19.91M--24.85M--------------0--0------------
Proceeds from stock option exercised by employees 17.39%27K73.68%891K78.71%470K3,600.00%37K57.64%361K15.00%23K-29.14%513K-47.50%263K-92.31%1K9.05%229K
Cash from discontinued financing activities
Financing cash flow 86,569.57%19.93M4,917.15%25.74M9,526.24%25.32M3,600.00%37K57.64%361K15.00%23K-29.14%513K-47.50%263K-92.31%1K9.05%229K
Net cash flow
Beginning cash position -25.29%16.86M6.43%22.56M-50.25%15.09M-56.89%19.7M-53.51%13.67M6.43%22.56M-20.00%21.2M8.54%30.33M68.03%45.7M2.04%29.4M
Current changes in cash 54.07%-4.09M-518.71%-5.71M122.77%1.77M69.98%-4.62M-62.97%6.04M-208.53%-8.9M125.72%1.36M-15.17%-7.77M-2,163.22%-15.37M1,111.29%16.3M
End cash Position -6.56%12.77M-25.29%16.86M-25.29%16.86M-50.25%15.09M-56.89%19.7M-53.51%13.67M6.43%22.56M6.43%22.56M8.54%30.33M68.03%45.7M
Free cash flow 2.55%-16.43M-25.56%-54.55M-21.70%-12M-17.12%-11.16M-27.20%-14.53M-33.46%-16.86M26.13%-43.45M23.12%-9.86M34.67%-9.53M17.79%-11.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More